Navigation Links
Herbalife Protein Shake Proven Effective in Clinical Study

LOS ANGELES, March 20 /PRNewswire/ -- Over the past several decades, the United States has seen dramatic increases in the incidence of obesity. But the epidemic is not confined to this country; similar increases are being seen worldwide as other countries adopt Western high-calorie foods and a sedentary lifestyle.

Recent data from the National Statistics Office in Korea, for example, indicate that nearly a third of Koreans - about 10 million people - are overweight, with numbers increasing by about 400,000 annually.

Researchers at the Seoul National University Hospital in Korea recently reported that the use of meal replacements twice daily was an effective strategy for reducing body weight and body fat, and for improving indicators of obesity-related conditions.

The study, published in the February issue of the International Journal of Clinical Practice, followed 75 obese men and women with the metabolic syndrome - a cluster of factors including high blood pressure, a large waist measurement, elevated blood sugar and triglycerides, and low blood levels of "good" HDL cholesterol - for a period of 12 weeks.

All subjects replaced two meals a day with liquid meal replacements (Herbalife Formula 1, Korean formula) but were randomly assigned to consume a diet of either a standard amount of protein - about 15 percent of total calories - or double the amount of protein from a higher protein plan.

At the end of 12 weeks, both groups lost weight and both groups lost weight in the belly area. But, in the subjects who followed the diet most strictly, the people in the high protein group lost more body fat (and less lean body mass) than the people consuming the standard amount of protein.

"These findings indicate that meal replacements are a very valuable strategy for losing weight and body fat," said Belong Cho, M.D., Ph.D., of the Department of Family Medicine at Seoul National University Hospital and lead researcher on the study. "With the increasing incidence of overweight and obesity in Korea, there is a critical need to find ways to help individuals lose weight and decrease their risk of developing obesity-related disorders such as the metabolic syndrome," he added.

The incidence of the metabolic syndrome in Korea has increased from 18.6 percent to 23.6 percent between 1998 and 2001, paralleling similar increases - from 34.5 percent to 39 percent - over the same time period in the U.S. Dr. Cho added, "We have demonstrated the effectiveness of meal replacements for weight loss, and this approach could have far-reaching benefits in addressing obesity which has become a worldwide problem."

Cho is a member of Herbalife's Nutrition Advisory Board (NAB). The NAB is made up of leading experts around the world in the fields of nutrition and health who educate and train Herbalife independent distributors on the principles of nutrition, physical activity and healthy lifestyle.

The NAB is chaired by David Heber, M.D., Ph.D., director of the Center for Human Nutrition at the University of California, Los Angeles (UCLA).

About Herbalife Ltd.

Herbalife Ltd. is a global network marketing company that sells weight-management, nutrition, and personal care products intended to support a healthy lifestyle. Herbalife products are sold in 70 countries through a network of over 1.9 million independent distributors. The company supports the Herbalife Family Foundation and its Casa Herbalife program to bring good nutrition to children. Please visit Herbalife Investor Relations for additional financial information.

SOURCE Herbalife Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Herbalife Sued for Negligence and Fraud by Victim
2. Plaintiffs Lawyer Orders Lead Testing on 3 Popular Herbalife Products; Results Show 728% More Lead Than Allowed by Law Under Proposition 65 Violation
3. New Lab Tests Reveal Herbalife, Usana Have 1,000 Times the Lead as Ensure, Boost
4. New Lab Tests Reveal Herbalife, Usana Have 1120% more Lead than Ensure, Boost
5. Herbalife Names Managing Director of Its South America Region
6. Venezuelan Kidney Expert Joins Herbalifes Nutrition Advisory Board
7. Draining away brains toxic protein to stop Alzheimers
8. Penn study finds pro-death proteins required to regulate healthy immune function
9. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
10. Emory researchers identify signaling protein for multiple myeloma
11. Human C-reactive protein regulates myeloma tumor cell growth and survival
Post Your Comments:
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... non-traumatic limb amputations in the United States. Podiatrists are well aware that psychology-based ... adopt therapeutic behaviors) are often catastrophic contributors to diseases of the diabetic foot. ...
(Date:12/1/2015)... ... December 01, 2015 , ... For the ... is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch free hydrophilic ... the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President North America. ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, the leader ... in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the ... finalist in the category of Digital Solutions for its innovative, industry-leading product, Alme ...
(Date:12/1/2015)... ... 2015 , ... TCS Healthcare Technologies (TCS), a leading provider ... is pleased to announce that VIP Care Services, a Caprock Health Group affiliate ... Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY Complete ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... BOSTON , December 1, 2015 Russia ... phase III clinical trials. 70% of new drugs registered in ... trials in Russia . --> Russia has ... trials. 70% of new drugs registered in Europe ... . --> Russia has always been ...
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: